Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 1.000 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.561 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.555 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.531 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.530 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.515 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.512 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.511 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.507 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.507 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.507 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.506 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.506 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.505 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.503 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.502 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.500 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.500 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.500 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.497 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.497 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.496 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.495 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.495 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.494 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.492 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.490 | |
| 4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.490 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.490 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.488 | |
| 1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.486 | |
| 2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.486 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.486 | |
| 4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.485 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.484 | |
| 4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.484 | |
| 4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.484 | |
| 3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.483 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.482 | |
| 4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.482 | |
| 1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.481 | |
| 4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.481 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.481 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.480 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.479 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.479 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.478 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.478 | |
| 2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.477 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.477 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.476 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.476 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.476 | |
| 2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.475 | |
| 3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.475 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
| 3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.473 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.472 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.472 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
| 3w0p | ADP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.471 | |
| 4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.471 | |
| 4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.471 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.471 | |
| 2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.470 | |
| 3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.470 | |
| 3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.470 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.470 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.469 | |
| 1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.469 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.469 | |
| 4eut | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.469 | |
| 4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.469 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.468 | |
| 2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.468 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.468 | |
| 3lmg | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.468 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.468 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.468 | |
| 3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.467 | |
| 4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.467 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.466 | |
| 2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.466 | |
| 3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.466 | |
| 2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.465 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.465 | |
| 2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.465 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.465 | |
| 3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.465 | |
| 4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.465 | |
| 2x6d | X6D | Aurora kinase A | 2.7.11.1 | 0.464 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.463 | |
| 3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.463 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.462 | |
| 2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.462 | |
| 2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.462 | |
| 4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.462 | |
| 5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.462 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.461 | |
| 2itx | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
| 2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.461 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.461 | |
| 2zm4 | KSM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.461 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.461 | |
| 2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.460 | |
| 2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.460 | |
| 3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.460 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.460 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.460 | |
| 1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.459 | |
| 3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.459 | |
| 4fad | 0TB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.459 | |
| 4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.459 | |
| 4tv3 | ML9 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | / | 0.459 | |
| 1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.458 | |
| 3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.458 | |
| 3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.458 | |
| 4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.458 | |
| 4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.458 | |
| 5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.458 | |
| 1mqb | ANP | Ephrin type-A receptor 2 | 2.7.10.1 | 0.457 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.457 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.457 | |
| 3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.456 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.456 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.456 | |
| 1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
| 2pe2 | 464 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
| 2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.455 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.455 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.455 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.455 | |
| 4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
| 1uu3 | LY4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.454 | |
| 2g2f | AGS | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.454 | |
| 2itu | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.454 | |
| 2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.454 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.454 | |
| 1pjk | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.453 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.453 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.453 | |
| 2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.453 | |
| 3e8e | G98 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.453 | |
| 3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
| 3qcs | 3Q1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
| 2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 3w0n | ANP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.452 | |
| 4e73 | 0NR | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.452 | |
| 4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
| 4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.451 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.451 | |
| 5c8w | PCG | cGMP-dependent protein kinase 2 | 2.7.11.12 | 0.451 | |
| 2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.450 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.450 | |
| 1d4a | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.449 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.449 | |
| 4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.449 | |
| 4izy | 1J2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.449 | |
| 1h66 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.448 | |
| 2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
| 2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
| 3lj3 | WYE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.448 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.448 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.448 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.448 | |
| 3qd4 | 3Q6 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.447 | |
| 4ajw | VWN | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | 2.7.1.153 | 0.447 | |
| 4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.447 | |
| 4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.447 | |
| 4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.447 | |
| 2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.446 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.446 | |
| 3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.446 | |
| 3w0s | ANP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.446 | |
| 4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.446 | |
| 4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.446 | |
| 5eg3 | ACP | Fibroblast growth factor receptor 2 | / | 0.446 | |
| 1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.445 | |
| 1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.445 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.445 | |
| 3bqr | 4RB | Death-associated protein kinase 3 | / | 0.445 | |
| 3d7t | STU | Tyrosine-protein kinase CSK | / | 0.445 | |
| 4kzo | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.445 | |
| 4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.445 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.445 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.445 | |
| 2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.444 | |
| 3nwq | 2NC | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
| 3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.444 | |
| 4agu | D15 | Cyclin-dependent kinase-like 1 | / | 0.444 | |
| 4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.444 | |
| 4f4p | 0SB | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.444 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.444 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.444 | |
| 4w9w | YDJ | BMP-2-inducible protein kinase | 2.7.11.1 | 0.444 | |
| 1h1w | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 3lu8 | IQX | Serum albumin | / | 0.443 | |
| 3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.443 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.443 | |
| 4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.443 | |
| 4im0 | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.443 | |
| 4ji9 | 1M3 | Tyrosine-protein kinase JAK2 | / | 0.443 | |
| 1kbq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.442 | |
| 1xdd | AAY | Integrin alpha-L | / | 0.442 | |
| 3c4x | ATP | Rhodopsin kinase | / | 0.442 | |
| 4q5j | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.442 | |
| 1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.441 | |
| 1u5r | ATP | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.441 | |
| 3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.441 | |
| 3qd3 | 3Q5 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
| 3t11 | 3T1 | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
| 4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
| 4c59 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.441 | |
| 4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
| 4y95 | 746 | Tyrosine-protein kinase | / | 0.441 | |
| 2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.440 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.440 | |
| 2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
| 2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
| 3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.440 | |
| 4anu | EM7 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
| 4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.440 | |
| 4j98 | ACP | Fibroblast growth factor receptor 2 | / | 0.440 | |
| 5a4k | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.440 |